XML 51 R35.htm IDEA: XBRL DOCUMENT v3.22.0.1
Share Based Payments and Employee Benefit Plans (Tables)
12 Months Ended
Dec. 31, 2021
Schedule of weighted average assumptions used in estimation of the fair value of options granted

For the Year Ended December 31, 

2021

2020

Risk-free interest rate

    

0.50%

1.45%

Expected lives (in years)

 

4.54

4.94

Expected volatility

77.55%

61.21%

Expected dividend yield

0.00%

0.00%

Fair value per share

$

1.96

$

3.13

Summary of activity, pricing and other information for the Company's stock options

For the Year Ended December 31, 

2021

2020

Weighted-

Weighted-

Average

Average

Number of

Exercise

Number of

Exercise

Shares

Price

Shares

Price

Options outstanding at the beginning of the year

    

524,357

    

$

8.58

    

914,470

    

$

8.10

    

Options granted

 

85,154

 

3.29

 

30,000

 

5.34

 

Options exercised

 

 

 

(9,500)

 

4.84

 

Options forfeited/cancelled

 

(39,283)

 

7.15

 

(410,613)

 

7.35

 

Options outstanding at the end of the period

 

570,228

7.89

 

524,357

8.58

 

Options exercisable at the end of the period

 

406,361

$

9.65

 

327,366

$

11.46

 

Schedule of aggregate intrinsic value

As of December 31, 

 

2021

2020

 

Weighted-

Weighted-

Average

Aggregate

Average

Aggregate

Remaining

Intrinsic

Remaining

Intrinsic

Life

Value

Life

Value

(Years)

(in thousands)

(Years)

(in thousands)

 

Options outstanding at end of year

    

6.17

    

$

-

    

6.77

    

$

-

Options exercisable at end of year

 

5.43

$

-

 

5.96

$

-

Schedule of additional information regarding stock options outstanding

Stock Options Outstanding

Options Exercisable

 

Weighted-

 

Average

Weighted-

Weighted-

 

Exercise

Remaining

Average

Average

 

Price

Number

Contractual

Exercise

Number

Exercise

 

Range

Outstanding

Life in Years

Price

Exercisable

Price

 

$

3.22 - 3.74

 

150,872

 

7.91

$

3.45

 

53,671

$

3.59

3.75 - 5.38

 

200,000

 

7.16

 

3.75

 

133,334

 

3.75

5.39 - 9.85

 

27,582

 

4.01

 

7.01

 

27,582

 

7.01

9.86 - 17.39

86,524

4.15

 

11.99

 

86,524

 

11.99

17.40 - 20.49

 

51,250

 

4.55

 

17.40

 

51,250

 

17.40

20.50 - 20.50

 

54,000

 

3.56

 

20.50

 

54,000

 

20.50

$

3.22 - 20.50

 

570,228

 

6.17

$

7.89

 

406,361

$

9.65

Restricted stock units (RSU's)  
Summary of activity, pricing and other information for the Company's

Weighted-

Average

Number of

Grant Date

Shares

Fair Value

RSUs outstanding at beginning of the year

    

267,221

    

$

5.04

RSUs granted

 

245,332

 

3.29

RSUs issued

 

(94,493)

 

4.78

RSUs forfeited/cancelled

 

(20,231)

 

3.29

RSUs outstanding at end of the period

 

397,829

$

4.11

Deferred stock units  
Summary of activity, pricing and other information for the Company's

Weighted-

Average

Number of

Grant Date

Shares

Fair Value

DSUs outstanding at the beginning of the year

    

54,500

    

$

6.61

    

DSUs granted

 

 

 

DSUs issued

 

 

 

DSUs forfeited/cancelled

 

 

 

DSUs outstanding at the end of the period

 

54,500

$

6.61